title: Microneedle arrays delivery of the conventional vaccines based on nonvirulent viruses.
abstract: Recently, microneedle arrays (MAs) have been developed for painless inoculation of vaccines and possess many prominent advantages, including convenience for inoculation, and exact delivery of vaccine to the exact epidermal and dermal or mucosal compartments which teem with antigen-presenting cells (APCs). Among different types of MAs, while the micro-environmental stimulus-responsive MAs represent one of the developmental trends in the field, the MAs combined with the conventional vaccines that are based on nonvirulent viruses, such as live attenuated or whole inactivated viruses, and antigen-encoding DNA viral vectors, have developed rapidly into the advanced stages, with certain products already on clinical trials. The pre- and clinical research outcomes showed that the painless MA delivery of the conventional vaccines through mammalian skin or mucosa can not only elicit robust systemic and even mucosal immunity to pathogens but also, in certain circumstances, redirect the immune response toward a specific Th1 pathway, resulting in cytotoxic T lymphocytes (CTL) to erase the cell-hidden pathogens, thanks to the robust adjuvant function of MAs exerted through damaging the contacted cells to release dangerous signals. This paper focuses on reviewing the latest research and advancements in MA delivery of the conventional vaccines that are based on nonvirulent viruses, underlining MA enhancement of the overall vaccine performance and the most advanced MA vaccine products that are relatively close to markets.
authors.affiliation: a School of Pharmacy, Anhui Medical University , Hefei , China , and.
authors.forename: Ning
authors.initials: N
authors.lastname: Li
authors.affiliation: b School of Medical Engineering, Hefei University of Technology , Hefei , China.
authors.forename: Ning
authors.initials: N
authors.lastname: Wang
authors.affiliation: a School of Pharmacy, Anhui Medical University , Hefei , China , and.
authors.forename: Xueting
authors.initials: X
authors.lastname: Wang
authors.affiliation: a School of Pharmacy, Anhui Medical University , Hefei , China , and.
authors.forename: Yuanyuan
authors.initials: Y
authors.lastname: Zhen
authors.affiliation: a School of Pharmacy, Anhui Medical University , Hefei , China , and.
authors.forename: Ting
authors.initials: T
authors.lastname: Wang
mesh_terms: D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D018928:Immunity, Mucosal / Q000276:immunology; D009339:Needles; D014611:Vaccination / Q000379:methods*; D014612:Vaccines / Q000008:administration & dosage*; D014780:Viruses / Q000276:immunology*
chemical_list: D014612:Vaccines
keywords: Adjuvant system; controlled temperature chain; immunization; intradermal vaccination; microneedle array; mucosal immunity; vaccine delivery